|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities: | |||||
| Provision for credit losses | |||||
| Deferred income tax expense (benefit) | |||||
| Depreciation, amortization and accretion, net | |||||
| Amortization of net premiums on securities | |||||
| Amortization of servicing assets | |||||
| Accretion of net discounts on loans | |||||
| Amortization of low income housing partnerships | |||||
| Gains on sale of loans | |||||
| Stock-based compensation | |||||
| Earnings on company owned life insurance | |||||
| Net change in fair value of equity investment with readily determinable fair value | |||||
| OREO valuation adjustment and loss on sale | |||||
| Proceed from OREO sale | |||||
| Origination of loans held-for-sale | |||||
| Proceeds from sales of loans held-for-sale | |||||
| Net change in: | |||||
| Accrued interest receivable | |||||
| Accrued interest receivable and other assets | |||||
| Accrued interest payable | |||||
| Accrued interest payable and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Net change in loans receivable | |||||
| Proceeds from matured, called, or paid-down AFS debt securities | |||||
| Purchase of company owned life insurance | |||||
| Purchase of AFS debt securities | |||||
| Purchase of equity investments | |||||
| Purchase of loans | |||||
| Purchase of FHLB stock | |||||
| Purchase of premises and equipment, net | |||||
| Net change in investments in low-income housing partnerships | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Net change in deposits | |||||
| Proceeds from stock option exercise | |||||
| Proceeds from FHLB advances | |||||
| Repayment of FHLB advances | |||||
| Proceeds from issuance of subordinated note, net of cost | |||||
| Repurchase of common stock | |||||
| Cash dividend paid on common stock | |||||
| Payments related to tax-withholding for vested restricted stock awards | |||||
| Net cash provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Cash paid during the period for: | |||||
| Income taxes | |||||
| Income taxes | |||||
| Federal | |||||
| State/Local | |||||
| California | |||||
| All other states | |||||
| Total income taxes paid | |||||
| Interest | |||||
| Supplemental noncash disclosure: | |||||
| Initial recognition of right-of-use assets | |||||
| New commitments to low income housing partnership investments | |||||
| Transfer of loan to OREO | |||||
Loading...